These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 14638486)

  • 1. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
    Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
    Vilchèze C; Jacobs WR
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
    Bollela VR; Namburete EI; Feliciano CS; Macheque D; Harrison LH; Caminero JA
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1099-104. PubMed ID: 27393546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China.
    Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X
    Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
    Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
    Abe C; Kobayashi I; Mitarai S; Wada M; Kawabe Y; Takashima T; Suzuki K; Sng LH; Wang S; Htay HH; Ogata H
    J Clin Microbiol; 2008 Jul; 46(7):2263-8. PubMed ID: 18508939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can inhA mutation predict ethionamide resistance?
    Vadwai V; Ajbani K; Jose M; Vineeth VP; Nikam C; Deshmukh M; Shetty A; Soman R; Rodrigues C
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):129-30. PubMed ID: 23146620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
    Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
    J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in
    Cao B; Mijiti X; Deng LL; Wang Q; Yu JJ; Anwaierjiang A; Qian C; Li M; Fang DA; Jiang Y; Zhao LL; Zhao X; Wan K; Liu H; Li G; Yuan X
    Infect Drug Resist; 2023; 16():3117-3135. PubMed ID: 37228658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.